F · Healthcare

Strategic Partners A/S (1TB0)

Biotechnology

Strategic Partners A/S (1TB0) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 1TB0

P/E ratio

18.00

Strategic Partners A/S (1TB0) — FAQ

What is 1TB0's P/E ratio?

The price-to-earnings (P/E) ratio for Strategic Partners A/S (1TB0) is 18.00 (data as of 2026-03-23).

Does Strategic Partners A/S pay a dividend?

Dividend yield is not available in the current snapshot for Strategic Partners A/S (1TB0). Check the MyAverix Finance app for the latest dividend data.

What sector is Strategic Partners A/S in?

Strategic Partners A/S (1TB0) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 1TB0 listed on?

1TB0 is listed on F.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)